Literature DB >> 30645666

[Importance of acetylsalicylic acid in primary prevention : ASCEND, ARRIVE and ASPREE as well as a meta-analysis by Rothwell et al.]

K Schrör1, S Nitschmann2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30645666     DOI： 10.1007/s00108-018-0541-z

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  17 in total

1.  Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus.

Authors:  Deepak L Bhatt; Tilo Grosser; Jing-Fei Dong; Douglas Logan; Walter Jeske; Dominick J Angiolillo; Andrew L Frelinger; Lanyu Lei; Juan Liang; Jason E Moore; Byron Cryer; Upendra Marathi
Journal:  J Am Coll Cardiol       Date:  2017-01-11       Impact factor: 24.094

Review 2.  Functional testing methods for the antiplatelet effects of aspirin.

Authors:  Karsten Schrör; Kurt Huber; Thomas Hohlfeld
Journal:  Biomark Med       Date:  2011-02       Impact factor: 2.851

Review 3.  From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.

Authors:  M John Chapman
Journal:  Pharmacol Ther       Date:  2006-09-15       Impact factor: 12.310

4.  Cardiovascular Disease and Risk Management: Review of the American Diabetes Association Standards of Medical Care in Diabetes 2018.

Authors:  James J Chamberlain; Eric L Johnson; Sandra Leal; Andrew S Rhinehart; Jay H Shubrook; Lacie Peterson
Journal:  Ann Intern Med       Date:  2018-04-03       Impact factor: 25.391

5.  Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.

Authors:  John J McNeil; Rory Wolfe; Robyn L Woods; Andrew M Tonkin; Geoffrey A Donnan; Mark R Nelson; Christopher M Reid; Jessica E Lockery; Brenda Kirpach; Elsdon Storey; Raj C Shah; Jeff D Williamson; Karen L Margolis; Michael E Ernst; Walter P Abhayaratna; Nigel Stocks; Sharyn M Fitzgerald; Suzanne G Orchard; Ruth E Trevaks; Lawrence J Beilin; Colin I Johnston; Joanne Ryan; Barbara Radziszewska; Michael Jelinek; Mobin Malik; Charles B Eaton; Donna Brauer; Geoff Cloud; Erica M Wood; Suzanne E Mahady; Suzanne Satterfield; Richard Grimm; Anne M Murray
Journal:  N Engl J Med       Date:  2018-09-16       Impact factor: 91.245

Review 6.  Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.

Authors:  Peter M Rothwell; Jacqueline F Price; F Gerald R Fowkes; Alberto Zanchetti; Maria Carla Roncaglioni; Gianni Tognoni; Robert Lee; Jill F F Belch; Michelle Wilson; Ziyah Mehta; Tom W Meade
Journal:  Lancet       Date:  2012-03-21       Impact factor: 79.321

7.  Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

Authors:  Peter M Rothwell; F Gerald R Fowkes; Jill F F Belch; Hisao Ogawa; Charles P Warlow; Tom W Meade
Journal:  Lancet       Date:  2010-12-06       Impact factor: 79.321

8.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

Authors:  Colin Baigent; Lisa Blackwell; Rory Collins; Jonathan Emberson; Jon Godwin; Richard Peto; Julie Buring; Charles Hennekens; Patricia Kearney; Tom Meade; Carlo Patrono; Maria Carla Roncaglioni; Alberto Zanchetti
Journal:  Lancet       Date:  2009-05-30       Impact factor: 79.321

Review 9.  Estimates of benefits and harms of prophylactic use of aspirin in the general population.

Authors:  J Cuzick; M A Thorat; C Bosetti; P H Brown; J Burn; N R Cook; L G Ford; E J Jacobs; J A Jankowski; C La Vecchia; M Law; F Meyskens; P M Rothwell; H J Senn; A Umar
Journal:  Ann Oncol       Date:  2014-08-05       Impact factor: 32.976

10.  Exploring Meaningful Patient Engagement in ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-term Effectiveness).

Authors:  Madelaine Faulkner; Jacqueline Alikhaani; Linda Brown; Henry Cruz; Desiree Davidson; Ken Gregoire; Lisa Berdan; Ty Rorick; W Schuyler Jones; Mark J Pletcher
Journal:  Med Care       Date:  2018-10       Impact factor: 2.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.